NanoViricides is a clinical-stage biopharmaceutical company that is developing a novel class of antiviral therapies. Their technology uses a nano-polymer backbone to create "nanoviricides" that are designed to trap and neutralize virus particles, mimicking the cell surface receptors that viruses use to infect cells.
Shelton
CT
2005
1–10
